Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) on Motor and Cognitive Symptoms in Progressive Supranuclear Palsy (PSP) (STIM-PSP)
| Registry | NCT04655079, acronym STIM-PSP |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: triple, treatment |
| Enrollment | 24 (Actual) |
| Sponsor | University of Salerno (Other) |
| Conditions | Progressive Supranuclear Palsy, Motor and Cognitive Symptoms |
| Interventions | Anodal transcranial direct current stimulation (a-tDCS), Sham Condition (Device) |
| Dates | start 2021-02-01, primary completion 2022-05-11, completion 2022-05-11, first posted 2020-12-04, last updated 2023-08-02 |
| Locations | 1 site in Italy |
Related Papers Related Patents Related Grants Related Experts
All trials for Progressive Supranuclear Palsy All trials for Motor and Cognitive Symptoms All trials of Anodal transcranial direct current stimulation (a-tDCS) All trials of Sham Condition
This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) on cognitive and motor symptoms in Progressive Supranuclear Palsy (PSP) over the left dorsolateral prefrontal cortex (dlPFC).
Progressive Supranuclear Palsy (PSP) is a rapidly progressive neurodegenerative disease characterized by deposition of tau and motor, cognitive and behavioral symptoms. Since no effective treatment is available, non-invasive brain stimulation techniques, such as tDCS, could be a valid complementary therapeutic approach. The tDCS modulates the spontaneous activity of the neural network by applying a direct current flow on the cortical brain areas (anodic or cathodic stimulation). Despite its efficacy in psychiatric disorders, the therapeutic use of tDCS in neurodegenerative diseases requires more systematic studies. The aim of this study is to verify the safety and efficacy of tDCS in PSP on motor, cognitive and behavioral symptoms.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Real tDCS group | Experimental | Device: Anodal transcranial direct current stimulation (a-tDCS) | Participants receive anodal tDCS on the left dlPFC for 5 days/week for 2 weeks |
| Sham group | Sham comparator | Device: Sham Condition | Participants receive sham stimulation on the left dlPFC for 5 days/week for 2 weeks |
Sex: All, ages: 40 Years to 89 Years
Inclusion Criteria: * Diagnosis of PSP according with Movement Disorder Society (MDS) criteria (Hoglinger et al., 2017); * Age > 40 and < 89 years; * Presence of a caregiver supportive the patient for all study procedure; * Ability to walk for at least 5 steps either independently or with a minimum support (another patients holding patient's arm or with a walker) Exclusion Criteria: * Presence of electrical stimulators (for example, pacemaker, Deep Brain Stimulation, DBS) * Difficult in understanding Italian language * Presence of severe sensory deficits (for example, visual or hearing impairments) * Education level <5 years * History of drug abuse * History of severe psychiatric disorders * History of transient ischemic attacks * Cortical or sub-cortical vascular lesions * Seizures or severe heart problems and previous neurosurgical operations * Absence of subjective cognitive deficits * MMSE (Mini-Mental State Examination) score <20 * Left-handedness
| Facility | City | Country | Status |
|---|---|---|---|
| Centro per le Malattie Neurodegenerative (CEMAND) Dipartimento di Medicina e chirurgia, Sezione Neuroscienze, Università di Salerno | Salerno | Italy |